Literature DB >> 12414501

ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.

Pauliina Kronqvist1, Nobuko Kawaguchi, Reidar Albrechtsen, Xiufeng Xu, Henrik Daa Schrøder, Behzad Moghadaszadeh, Finn Cilius Nielsen, Camilla Fröhlich, Eva Engvall, Ulla M Wewer.   

Abstract

Muscular dystrophy is characterized by muscle degeneration and insufficient regeneration and replacement of muscle fibers by connective tissue. New therapeutic strategies directed toward various forms of muscular dystrophy are needed to preserve muscle mass and promote regeneration. In this study we examined the role of the transmembrane ADAM12, a disintegrin and metalloprotease, which is normally associated with development and regeneration of skeletal muscle. We demonstrate that ADAM12 overexpression in the dystrophin-deficient mdx mice alleviated the muscle pathology in these animals, as evidenced by less muscle cell necrosis and inflammation, lower levels of serum creatine kinase, and less uptake of Evans Blue dye into muscle fibers. These studies demonstrate that ADAM12 directly or indirectly contributes to muscle cell regeneration, stability, and survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414501      PMCID: PMC1850802          DOI: 10.1016/S0002-9440(10)64431-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  85th ENMC International Workshop on Congenital Muscular Dystrophy. 6th International CMD Workshop. 1st Workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000, Naarden, The Netherlands.

Authors:  Francesco Muntoni; Pascale Guicheney
Journal:  Neuromuscul Disord       Date:  2002-01       Impact factor: 4.296

Review 2.  Remarkable roles of proteolysis on and beyond the cell surface.

Authors:  C P Blobel
Journal:  Curr Opin Cell Biol       Date:  2000-10       Impact factor: 8.382

3.  ADAM 12 protease induces adipogenesis in transgenic mice.

Authors:  Nobuko Kawaguchi; Xiufeng Xu; Rie Tajima; Pauliina Kronqvist; Christina Sundberg; Frosty Loechel; Reidar Albrechtsen; Ulla M Wewer
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  A metalloprotease-disintegrin participating in myoblast fusion.

Authors:  T Yagami-Hiromasa; T Sato; T Kurisaki; K Kamijo; Y Nabeshima; A Fujisawa-Sehara
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

5.  Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

Authors:  R Matsuda; A Nishikawa; H Tanaka
Journal:  J Biochem       Date:  1995-11       Impact factor: 3.387

Review 6.  Muscular dystrophy--reason for optimism?

Authors:  Edward A Burton; Kay E Davies
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

7.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.

Authors:  Masanori Asakura; Masafumi Kitakaze; Seiji Takashima; Yulin Liao; Fuminobu Ishikura; Tsuyoshi Yoshinaka; Hiroshi Ohmoto; Koichi Node; Kohichiro Yoshino; Hiroshi Ishiguro; Hiroshi Asanuma; Shoji Sanada; Yasushi Matsumura; Hiroshi Takeda; Shintaro Beppu; Michihiko Tada; Masatsugu Hori; Shigeki Higashiyama
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

8.  Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.

Authors:  Holly H Nguyen; Vianney Jayasinha; Bing Xia; Kwame Hoyte; Paul T Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

9.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

Authors:  Y Isaka; D K Brees; K Ikegaya; Y Kaneda; E Imai; N A Noble; W A Border
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

10.  Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.

Authors:  Elisabeth R Barton; Linda Morris; Antonio Musaro; Nadia Rosenthal; H Lee Sweeney
Journal:  J Cell Biol       Date:  2002-04-01       Impact factor: 10.539

View more
  23 in total

1.  A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection.

Authors:  Pascal Stuelsatz; Paul Keire; Ricardo Almuly; Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

2.  Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.

Authors:  Haiqing Yi; Joanna Gruszczynska-Biegala; Denise Wood; Zhefeng Zhao; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2005-04-23       Impact factor: 5.157

3.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

4.  Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.

Authors:  Megan L Cramer; Rui Xu; Paul T Martin
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

5.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

6.  Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice.

Authors:  Louise Helskov Jørgensen; Charlotte Harken Jensen; Ulla M Wewer; Henrik Daa Schrøder
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

7.  The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.

Authors:  Ashwani Mittal; Shephali Bhatnagar; Akhilesh Kumar; Estelle Lach-Trifilieff; Sandrine Wauters; Hong Li; Denys Y Makonchuk; David J Glass; Ashok Kumar
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

8.  Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.

Authors:  Rui Xu; Sarah DeVries; Marybeth Camboni; Paul T Martin
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

Review 9.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

10.  Potential role for ADAM15 in pathological neovascularization in mice.

Authors:  Keisuke Horiuchi; Gisela Weskamp; Lawrence Lum; Hans-Peter Hammes; Hui Cai; Thomas A Brodie; Thomas Ludwig; Riccardo Chiusaroli; Roland Baron; Klaus T Preissner; Katia Manova; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.